Related Experiment Video
Updated: Jul 16, 2026
07:17
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
Regulatory T cells and cancer
1Center for Cell and Gene Therapy, Departments of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Current Opinion in Immunology
|February 20, 2007
Summary
Regulatory T cells (Tregs) suppress immune responses, hindering cancer immunotherapy. Targeting Toll-like receptors may enhance Treg-based cancer treatments by modulating immune suppression.
Area of Science:
- Immunology
- Cancer Biology
- Immunotherapy
Background:
- Regulatory T cells (Tregs) are crucial for immune homeostasis and preventing autoimmunity.
- Tumor cells exploit Tregs to create an immunosuppressive tumor microenvironment, limiting anti-cancer immunity.
- Antigen-specific Tregs induce local immune tolerance, posing a challenge for effective cancer immunotherapy.
Purpose of the Study:
- To explore the role of Tregs in cancer immunotherapy.
- To investigate the potential of targeting Tregs to enhance anti-tumor immunity.
- To examine the influence of Toll-like receptors (TLRs) on Treg function in the context of cancer.
Main Methods:
- Characterization of tumor-specific Treg cells.
- Analysis of Treg cell recruitment and function within the tumor microenvironment.
- Investigating the direct regulation of human Treg cell suppressive activity by TLRs.
Main Results:
- Tregs can be recruited by tumors to inhibit anti-tumor immune responses.
- Tumor-specific Tregs induce local immune tolerance.
- Toll-like receptors directly modulate the suppressive activity of human Tregs.
Conclusions:
- Understanding Treg cell dynamics is critical for improving cancer immunotherapy.
- Targeting Treg cells, potentially via TLR modulation, offers a promising strategy to overcome tumor-induced immune suppression.
- Co-administration of TLR ligands and antigenic peptides may enhance the efficacy of cancer vaccines and immunotherapies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...